A Life in Letters – a Column by Jamie Hughes, Columns Cold? What Cold?!

Columns, Fall Down, Get Up Again- a Column by John Connor How ‘The Terminator’ Changed John Connor

Columns, The MS Wire - A Column by Ed Tobias I’ve Had Success with the Bioness L300 Go This Time Around

News FDA Approves Three Generic Versions of Novartis’ Gilenya for Treating Relapsing MS

News Signaling Protein of Intestines May Trigger Nervous System Inflammation in MS, Study Says

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: Why Are UTIs Problematic for People with MS?

Columns, Silver Linings - a Column by Jennifer Powell Thankful Awakening: Accepting Change with SPMS

News 3D Nerve Cell Models of PPMS, Parkinson’s Ready for Liftoff to Space Station for Long-term Study in Microgravity

News $1M Gift to MS Society of Canada to Support New Tools for Better Therapy Decisions

News National MS Society Establishes Partnership with Jon Strum’s ‘RealTalk MS’ Podcast

News CMSC Joins NeurologyLive Program for Specialists Caring for Those with MS, Like Diseases

Columns, DISabled to ENabled – a Column by Jessie Ace Can My Mind Control My MS Symptoms?

News microRNA Found in Gut Microbiome May Unlock Future Therapeutic Approach for MS

News Online MS ‘Toolkit’ Created by University Psychologist to Help in Managing Pain and Fatigue

News MS Risk Linked to Herpes Virus 6A and Not More Common 6B, Study Suggests

News, SPMS Mount Sinai Taking Part in Phase 2 Trial of NurOwn Cell Therapy in Progressive MS

Sponsored Content Because of the critical role the brain plays in multiple sclerosis (MS), many experts ...

Columns, MSunderstood Millennial - a Column by Stephanie Towler Each MS Journey Is Different, So Be Kind

News Profit and Competitors’ Prices Major Drivers of MS Therapy Costs in US, Pharma Execs Say

News MS Specialist to Lead Trial of Temelimab in Progressing Disease Without Relapses

Columns, DISabled to ENabled – a Column by Jessie Ace From New Hope Emerged an Old Nightmare

News Problems Processing Sensory Information Linked to MS Severity, Difficulties in Daily Life, Study Finds

News GI Symptoms with Vumerity Fewer and Milder Than Tecfidera, Phase 3 Trial Shows

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Immunoadsorption, MS Therapies Approval, Cannabis-based Capsules for Study, Pregnancy and MS

News Gut Microbiome Changes Evident in Newly Diagnosed MS Patients, Study Says

News Protein That Helps Cells Break Down Sugar Also Promotes Inflammation, Study Suggests

A Life in Letters – a Column by Jamie Hughes, Columns Making (and Appreciating) Space

Columns, The MS Wire - A Column by Ed Tobias It’s Freezing and I’m Stuck on My Scooter

News Black and Hispanic RRMS Patients Show High Levels of Immune Cells Linked to Antibodies, US Study Reports

News, SPMS Ocrevus Top Choice of US Neurologists for Active SPMS, But Mayzent and Mavenclad Gaining Interest, Report Says

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: MS and Drowsy Driving

Columns, Silver Linings - a Column by Jennifer Powell Painsomnia Unravels Me from Inside Out

News Immunoadsorption May Be Superior to Plasma Exchange in Treating Steroid-resistant Relapses in MS

News WCN 2019 Discussions Point to Failures of Regulators to Make MS Therapies Available

News MMJ Enters Agreement to Produce Cannabis-based Capsules for Clinical Trials in MS and Huntington’s

News Pregnancy Does Not Change Long-term Course of MS, New Data Suggest

News Blocking Molecule Prevents B-cells from Entering Brain and Promoting MS Progression, Study Reports

News NMSS Awards $495K to Study Biomarkers in Phase 2 Trial of NurOwn in Progressive MS

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Mayzent in EU for SPMS; Depression, Fatigue, and Quality of Life; Acthar Gel; Soothie Cushion

News Novel MRI Marker Better at Predicting MS Progression, Study Reports

News, SPMS Mayzent Approved in Australia as First Treatment for Secondary Progressive MS

Columns, Fall Down, Get Up Again- a Column by John Connor This Could Be the Last Time

Alexa, News, SPMS CHMP Favors Mayzent as Oral Treatment Specifically for Active SPMS Patients in EU

Columns, The MS Wire - A Column by Ed Tobias Is It Good that Google Is Crunching Our Healthcare Data?

News Weill Neurohub Unites 3 Academic Centers with DOE Scientists to Advance Tools, Treatments for MS and Other Ills

News Depression, Fatigue Influence Health-related Quality of Life More Than Physical Impairment of MS, Study Reveals

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: 21st-century Medicine Models

Columns, Silver Linings - a Column by Jennifer Powell Filtering Ads and Choosing What’s Best

News Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says

News 7T MRI Reveals New Insights into Some RRMS Features

News Single Dose of CD45-ADC Resets the Immune System, Delays the Onset of MS in Mice

News Sativex, Cannabis Extract for MS Spasticity, Now Available to Select Patients in England

News Long-term IFN-Beta Treatment Normalizes Immune Balance in RRMS, Study Shows

News Acthar Gel Quite Effective at Resolving Relapses as Alternative to Corticosteroids, Study Reports

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: EU Lemtrada Safety Guidance, Targeted Treatment Project, SPMS Patients Unaware of Diagnosis

News, SPMS Early Damage on Brain Scans and Greater 5-Year Disability Help Predict 30-Year Outcomes in MS, Study Finds

News Low Neurite Density in Spinal Cord Linked to Greater Physical Disability in RRMS Patients

A Life in Letters – a Column by Jamie Hughes, Columns Simple Signs with Messages of Hope Resonate with Me

Columns, Fall Down, Get Up Again- a Column by John Connor MS Really Enjoys Hitting Below the Belt

Columns, The MS Wire - A Column by Ed Tobias Top MS Worries Highlight the Need for a Comprehensive Care Program

News ‘Soothie Cushion’ Designed to Regulate Body Temperature in Travelers With MS, Other Disabilities

News 2 Potassium Channels Key to Fast Transmission of Impulses Along Myelin-rich Nerve Fibers, Study Shows

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: Does Brain Matter Matter?

Columns, Silver Linings - a Column by Jennifer Powell Choosing Calm Over Chaos: Quieting Myself While Living with SPMS

News Generic Version of Gilenya, pms-Fingolimod, Now Available for RRMS Patients in Canada

News Siemens Healthineers Joins with Quanterix to Develop Blood Tests for NfL Levels

Columns, Making a Difference - a Column by Cathy Chester. The Past Gives Us Hope for the Future

News Specific FOXP3 Mutation Linked to Greater Likelihood of MS in Brazilian Women, Study Reports

News European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

News Employed MS Patients Have Lower Productivity, Reduced Health-related Quality of Life, Study Shows

News EMA Safety Group Advises Lemtrada Be Limited to ‘Highly Active’ RRMS Patients at Hospitals with ICUs

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Vumerity Approval, Low Antibody Levels in MS Patients, GA Depot Trial, Tecfidera Study

News Teva-Fingolimod, Generic and Bioequivalent Version of Gilenya, Available in Canada

News Mutations in 3 Genes Linked to Vision Loss and MS Severity in Hopkins Study

Columns, The MS Wire - A Column by Ed Tobias My Lemtrada Journey: Observations at 18 Months After Round 2

News, SPMS Study: 40% of SPMS Patients in Italy and Germany Unaware of Diagnosis

News Interferons Superior to Glatiramer Acetate, and Tysabri More Effective than Gilenya for RRMS, Real-world Study Finds

Sponsored Content The brain is made up of two types of tissue: grey matter and white ...

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: What Is Lesion Load?

Columns, Silver Linings - a Column by Jennifer Powell MS and Mythological Mends: Hope Is My Cure for Today

News Medicinal Cannabinoids Not Effective for Mental Disorders, Small Relief on MS Anxiety, Analysis Suggests

News Brain Bank at Harvard Gets Potential $12.8M from NIH to Support Brain Donations for MS and Other Research

News, SPMS Vumerity Approved in US as Treatment for RRMS and Active SPMS

News First Relapsing MS Patient Enrolled in Phase 3 Trial of Mapi Pharma’s Once-monthly Glatiramer Formulation

News Unemployment Risk Factors in MS Vary with Age, Study Suggests

News UV-B Light Prevents MS Symptoms in Mice Independently of Vitamin D, Study Finds

News Levels of Infection-fighting Antibodies Low in Blood of People with MS, Study Finds

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Cognitive Impairment, Genetic Variant Risk Factor, Protein Biomarkers, Gilenya Study

News AP-1 Transcription Factor Family is Critical for Healthy T-cell Development, Study Says

News Altered Fear Response, Changes in Brain Chemistry Seen in Mice with Poor Gut Microbiota

A Life in Letters – a Column by Jamie Hughes, Columns Mystery Keeps Me Pushing Forward: I Wonder What I’ll Do Next

Columns, Fall Down, Get Up Again- a Column by John Connor Pip, Pip, Hooray! Months of Work and Worry Pay Off

Columns, The MS Wire - A Column by Ed Tobias Am I Too Old for Aggressive MS Treatment?

News Higher Intellectual Ability, Early-life Physical Activity May Protect Against Cognitive Impairment in MS, Study Suggests

News Twice Daily Dosing and Side Effects Top Reasons Patients Seen to Stop Tecfidera in Small Study

Columns, MS in Moderation – a Column by Tamara Sellman Need to Know: How MS Affects Memory

Columns, Silver Linings - a Column by Jennifer Powell MS and Anxiety: Be Kind to Yourself and Ask for Help

News SARM1 Inhibitors Protect Neurons from Damage in Mice and Cell Cultures, Results Presented at Neuroscience 2019 Show

News Potential RRMS Fumarate Treatment Free of ‘Flush’ Effect to Enter Trial in 2020, Vitalis Says

News, SPMS NfL and CHI3L1 Work as Biomarkers of Disease Activity and Progression in MS, Study Says